Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daniel F. Hanley, MD
Johns Hopkins University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
81 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital Sao Jose, Joinville
Joinville, Santa Catarina, Brazil
- Hospital de Clinicas de Porto Alegre
Porto Alegre, Brazil
- Hospital de Pronto Socorro de Porto Alegre
Porto Alegre, Brazil
- Hospital de Clinicas de Ribeirao Preto
Ribeirão Preto, Brazil
- Hospital Sao Paulo Universidade Federal de Sao Paulo / Unifesp
São Paulo, Brazil
- University of Alberta
Edmonton, Alberta, Canada
- Montreal Neurological Institute at Mcgill University
Montreal, Quebec, Canada
- University of Erlangen
Erlangen, Germany
- University of Halle
Halle, Germany
- University of Heidelberg
Heidelberg, Germany
- University of Leipzig
Leipzig, Germany
- University of Mainz
Mainz, Germany
- University of Tubingen
Tübingen, Germany
- University of Szeged
Szeged, Csongrád megye, Hungary
- Honved Korhaz
Budapest, Hungary
- University of Debrecen
Debrecen, Hungary
- University of Pecs
Pécs, Hungary
- Rambam Medical Center
Haifa, Israel
- Hadassah Hebrew University Hospital
Jerusalem, Israel
- Chaim Sheba Medical Center
Ramat Gan, Israel
- Sourasky Medical Center
Tel Aviv, Israel
- Bellvitge Hospital
Barcelona, Spain
- Hospital de la Santa Creu I Sant Pau
Barcelona, Spain
- Vall D'Hebron University Hospital
Barcelona, Spain
- University of Zurich
Zurich, Canton of Zurich, Switzerland
- University Hospital, Inselpital, Bern
Bern, Switzerland
- Salford Royal Nhs Foundation Trust
Salford, Manchester, United Kingdom
- Newcastle General Hospital
Newcastle upon Tyne, United Kingdom
- University of Southampton Hospital
Southampton, United Kingdom
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- Mayo Clinic, Arizona
Phoenix, Arizona, United States
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- University of California Los Angeles
Los Angeles, California, United States
- University of Southern California - Keck School of Medicine
Los Angeles, California, United States
- Stanford University
Palo Alto, California, United States
- Hartford Hospital
Hartford, Connecticut, United States
- Yale University
New Haven, Connecticut, United States
- Georgetown University
Washington D.C., District of Columbia, United States
- Mayo Clinic, Jacksonville
Jacksonville, Florida, United States
- Intercoastal Medical Center
Sarasota, Florida, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2009
- Primary completion
- 31 Jul 2015
- Completion
- 31 Jan 2016
- Last update posted
- 5 Dec 2018
- Registered enrollment
- 500
- Registry id
- NCT00784134
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.